One of the key experimental approaches to elucidate the function of a gene in vivo is the selective ablation of its expression or activity by one of several loss-of-function (LOF) approaches.

Scientists at deCODE genetics, a subsidiary of Amgen,�reveal today in Nature Genetics associations between rare loss-of-function variants in two genes and bipolar disorder. Significant progress has ...

Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators. Please wait a minute before you try to comment again.